1. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies;Arbabi Ghahroudi;FEBS Lett.,1997
2. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K., 1989. Current Protocols in Molecular Biology, Wiley, New York.
3. The crystal structures of complexes formed between lysozyme and antibody fragments;Bentley;EXS,1996
4. Use of mutator cells as a means for increasing production levels of a recombinant antibody directed against Hepatitis B;Coia;Gene,1997
5. Effects of genetic engineering on the pharmacokinetics of antibodies;Colcher;Q. J. Nucl. Med.,1998